Video: Sen. Cornyn is proud to have bipartisan support in South Texas

Mega Doctor News WASHINGTON, D.C. – U.S. Department of Health and Human Services...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center. 

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.

Driven by its mission to heal even the most critically ill patients across the Rio Grande Valley, DHR Health recently provided extracorporeal membrane oxygenation (ECMO) to its 100th patient since the program’s inception in 2023. ECMO is medicine’s most sophisticated life support system that can save lives even when a ventilator and strong medications cannot.